Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001234944 | SCV001407605 | uncertain significance | Bardet-Biedl syndrome | 2021-08-24 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine with tyrosine at codon 410 of the BBS10 protein (p.His410Tyr). The histidine residue is highly conserved and there is a moderate physicochemical difference between histidine and tyrosine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with BBS10-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001834034 | SCV002091771 | uncertain significance | Bardet-Biedl syndrome 10 | 2020-11-06 | no assertion criteria provided | clinical testing |